Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
- 22 July 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (1) , 194-199
- https://doi.org/10.1016/j.bbrc.2005.05.095
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Characterization of SARS main protease and inhibitor assay using a fluorogenic substrateBiochemical and Biophysical Research Communications, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- Mechanisms and enzymes involved in SARS coronavirus genome expressionJournal of General Virology, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- The 3C-Like Proteinase of an Invertebrate Nidovirus Links Coronavirus and Potyvirus HomologsJournal of Virology, 2003
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsProtein Engineering, Design and Selection, 1995